EGFR and non-small cell lung carcinoma: In vitro studies have shown that romidepsin depletes expression of epidermal growth factor receptor (EGFR), erbB2 and Raf-1 kinases in NSCLC cells and resulted in time-dependent apoptosis in cells expressing wild-type (wt) or mutant EGFR [50].